Cargando…

N-Terminal Pro-B-Type Natriuretic Peptide in Risk Stratification of Heart Failure Patients With Implantable Cardioverter-Defibrillator

BACKGROUND: The prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in heart failure (HF) is well-established. However, whether it could facilitate the risk stratification of HF patients with implantable cardioverter-defibrillator (ICD) is still unclear. OBJECTIVE: To determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Yu, Cheng, Si-Jing, Hua, Wei, Cai, Min-Si, Zhang, Ni-Xiao, Niu, Hong-Xia, Chen, Xu-Hua, Gu, Min, Cai, Chi, Liu, Xi, Huang, Hao, Zhang, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921256/ https://www.ncbi.nlm.nih.gov/pubmed/35299981 http://dx.doi.org/10.3389/fcvm.2022.823076

Ejemplares similares

Toward Better Risk Stratification for Implantable Cardioverter-Defibrillator Recipients: Implications of Explainable Machine Learning Models
por: Deng, Yu, et al.
Publicado: (2022)

Independent and joint association of N-terminal pro-B-type natriuretic peptide and left ventricular mass index with heart failure risk in elderly diabetic patients with right ventricular pacing
por: Yu, Yu, et al.
Publicado: (2022)

Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks
por: Sun, Xuerong, et al.
Publicado: (2021)

Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators
por: Lee, Douglas S., et al.
Publicado: (2015)

Prognostic value of N-terminal Pro–B-Type natriuretic peptide in patients with intermediate coronary lesions
por: Song, Chenxi, et al.
Publicado: (2022)

N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study
por: Luo, Changjun, et al.
Publicado: (2019)

Quality of Life in Patients with an Implantable Cardioverter Defibrillator: A Systematic Review
por: Tomzik, Juliane, et al.
Publicado: (2015)

Non-linear Association Between Body Mass Index and Ventricular Tachycardia/Ventricular Fibrillation in Patients With an Implantable Cardioverter-Defibrillator or Cardiac Resynchronization Therapy Defibrillator: A Multicenter Cohort Study
por: Zhou, Bin, et al.
Publicado: (2020)

Absence of Obesity Paradox in All-Cause Mortality Among Chinese Patients With an Implantable Cardioverter Defibrillator: A Multicenter Cohort Study
por: Zhou, Bin, et al.
Publicado: (2021)

Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators
por: Huang, Hao, et al.
Publicado: (2022)

B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review
por: Cavalcante, Pâmela Nogueira, et al.
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Prognostic Significance of Preprocedural N-Terminal Pro-B-Type Natriuretic Peptide Assessment in Diabetic Patients With Multivessel Coronary Disease Undergoing Revascularization
por: Wang, Le, et al.
Publicado: (2021)

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and Glomerular Filtration Rate in Patients With Acute Heart Failure
por: Wang, Kai, et al.
Publicado: (2020)

Prognosis Implication of N-Terminal Pro-B-Type Natriuretic Peptide in Adult Patients With Acute Myocarditis
por: Zhao, Yan, et al.
Publicado: (2022)

Interaction between electrical storm and left ventricular ejection fraction as predictors of mortality in patients with implantable cardioverter defibrillator: A Chinese cohort study
por: Zhai, Zhengqin, et al.
Publicado: (2022)

Dual tachycardia induced by electrocution terminated by an implantable cardioverter-defibrillator
por: Kocovic, Nikola, et al.
Publicado: (2023)

Association of N-Terminal Pro-brain Natriuretic Peptide With Volume Status and Cardiac Function in Hemodialysis Patients
por: Wang, Yaqiong, et al.
Publicado: (2021)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
por: Marini, Massimiliano, et al.
Publicado: (2023)

Sex Differences in Physical Activity and Its Association With Cardiac Death and All-Cause Mortality in Patients With Implantable Cardioverter-Defibrillators
por: Li, Xiaoyao, et al.
Publicado: (2020)

Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
por: Regoli, François D., et al.
Publicado: (2023)

Sex and N-terminal pro B-type natriuretic peptide: The potential mediating role of iron biomarkers
por: Khatami, Farnaz, et al.
Publicado: (2022)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

N-terminal pro-brain natriuretic peptide and adverse outcomes in Chinese patients with hypertrophic cardiomyopathy
por: Zhang, Zeng-Lei, et al.
Publicado: (2022)

Lead Abandonment and Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation in a Cohort of Patients With ICD Lead Malfunction
por: Russo, Vincenzo, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Intrapericardial Implantation of an Implantable Cardioverter-Defibrillator in a Child
por: Seong, Yong Won, et al.
Publicado: (2011)

Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide
por: Nordling, Pauliina, et al.
Publicado: (2016)

Brugada Syndrome: The Role of Risk Stratification in Selecting Patients for Implantable Cardioverter-defibrillator Placement
por: Mankbadi, Michael, et al.
Publicado: (2018)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
por: Jin, Jifu, et al.
Publicado: (2023)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Racial differences in setting of implantable cardioverter-defibrillator placement in older adults with heart failure and association with disparate post-implant outcomes
por: Akhabue, Ehimare, et al.
Publicado: (2023)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v5pc492trqkk2hcfqt82taqbmk